Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-03

Clinical Trial Update: Safety Study of Lifitegrast to Treat Dry Eye [Phase 3]

View source ↗

Summary

Phase 3 safety study of lifitegrast for dry eye disease completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lifitegrast (lifitegrast)

Snippet

Sponsor: Shire | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-10-03